Browse by Research Center

Article

Ali, Talib and Pisanti, Simona and Ciaglia, Elena and Mortarini, Roberta and Anichini, Andrea and Santinami, Mario and Gulletta, Elio and Ietto, Caterina and Galgani, Mario and Garofalo, Cinzia and Matarese, Giuseppe and Bifulco, Maurizio and Ferrone, Soldano and Colucci, Francesco and Moretta, Alessandro and Kärre, Klas and Carbone, Ennio (2014) Enrichment of KIR+CD57+ highly cytotoxic NK cells in sentinel lymph nodes of melanoma patients. Journal of Translational Medicine, 12 (Suppl ). P10 - P10. ISSN 1479-5876

Butterfield, LH and Economou, JS and Gamblin, TC and Geller, DA (2014) Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. Journal of Translational Medicine, 12 (1).

Concha-Benavente, Fernando and Ferris, Robert L (2014) IFNγ-induced PD-L1 expression is JAK2 but not JAK1 dependent and its inhibition enhances NK-cetuximab mediated ADCC of HNSCC cells. Journal for ImmunoTherapy of Cancer, 2 (S3).

De Moura, MB and Uppala, R and Zhang, Y and Van Houten, B and Goetzman, ES (2014) Overexpression of mitochondrial sirtuins alters glycolysis and mitochondrial function in HEK293 cells. PLoS ONE, 9 (8).

Feng, R and Milcarek, CA and Xie, XQ (2014) Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion. BMC Pharmacology and Toxicology, 15 (1).

Ferris, Robert L and Cohen, Ezra and Gash, Kelly and Whiting, Sam and Manjarrez, Kristi and Dietsch, Greg and Hershberg, Robert and Bryan, James (2014) Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Journal for ImmunoTherapy of Cancer, 2 (Suppl ). P69 - P69. ISSN 2051-1426

Fu, X and Creighton, CJ and Biswal, NC and Kumar, V and Shea, M and Herrera, S and Contreras, A and Gutierrez, C and Wang, T and Nanda, S and Giuliano, M and Morrison, G and Nardone, A and Karlin, KL and Westbrook, TF and Heiser, LM and Anur, P and Spellman, P and Guichard, SM and Smith, PD and Davies, BR and Klinowska, T and Lee, AV and Mills, GB and Rimawi, MF and Hilsenbeck, SG and Gray, JW and Joshi, A and Osborne, CK and Schiff, R (2014) Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase. Breast Cancer Research, 16 (5). ISSN 1465-5411

Gao, C and Xiao, G and Hu, J (2014) Regulation of Wnt/β-catenin signaling by posttranslational modifications. Cell and Bioscience, 4 (1).

Gao, Y and Trivedi, S and Ferris, RL and Koide, K (2014) Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells. Scientific Reports, 4.

Gough, AH and Chen, N and Shun, TY and Lezon, TR and Boltz, RC and Reese, CE and Wagner, J and Vernetti, LA and Grandis, JR and Lee, AV and Stern, AM and Schurdak, ME and Taylor, DL (2014) Identifying and quantifying heterogeneity in high content analysis: Application of heterogeneity indices to drug discovery. PLoS ONE, 9 (7).

Hong, CS and Muller, L and Boyiadzis, M and Whiteside, TL (2014) Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS ONE, 9 (8).

Horne, ZD and Clump, DA and Vargo, JA and Shah, S and Beriwal, S and Burton, SA and Quinn, AE and Schuchert, MJ and Landreneau, RJ and Christie, NA and Luketich, JD and Heron, DE (2014) Pretreatment SUV<inf>max</inf> predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy. Radiation Oncology, 9 (1).

Lam, W and Jiang, Z and Guan, F and Hu, R and Liu, SH and Chu, E and Cheng, YC (2014) The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018). BMC Complementary and Alternative Medicine, 14 (1).

Lee, CPL and Irwanto, A and Salim, A and Yuan, JM and Liu, J and Koh, WP and Hartman, M (2014) Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population. Breast Cancer Research, 16 (3). ISSN 1465-5411

Li, Jing and Ferris, Robert L (2014) Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment. Journal for ImmunoTherapy of Cancer, 2 (S3).

Li, Jing and Ferris, Robert L (2014) PD-1/SHP-2 negatively regulate Tc1/Th1 phenotypic responses and activation of T cells in the tumor microenvironment. Journal for ImmunoTherapy of Cancer, 2 (S3).

Mehan, MR and Williams, SA and Siegfried, JM and Bigbee, WL and Weissfeld, JL and Wilson, DO and Pass, HI and Rom, WN and Muley, T and Meister, M and Franklin, W and Miller, YE and Brody, EN and Ostroff, RM (2014) Validation of a blood protein signature for non-small cell lung cancer. Clinical Proteomics, 11 (1). ISSN 1542-6416

Ohkuri, Takayuki and Ghosh, Arundhati and Kosaka, Akemi and Zhu, Jianzhong and Ikeura, Maki and David, Michael and Watkins, Simon C and Sarkar, Saumendra N and Okada, Hideho (2014) STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment. Journal for ImmunoTherapy of Cancer, 2 (Suppl ). P228 - P228. ISSN 2051-1426

Patricia, Santos and Alexander, Etheridge and Gambotto, Andrea and Butterfield, Lisa H (2014) Transduction of human dendritic cells with adenovirus encoding anti-PD-1 reduces PD-1 expression on co-cultured T cells. Journal for ImmunoTherapy of Cancer, 2 (S3).

Starkweather, AR and Sherwood, P and Lyon, DE and Bovbjerg, DH and Broaddus, WC and Elswick, RK and Sturgill, J (2014) Depressive symptoms and cytokine levels in Serum and Tumor Tissue in patients with an Astrocytoma: A pilot study. BMC Research Notes, 7 (1).

Tarhini, AA and Lin, Y and Yeku, O and LaFramboise, WA and Ashraf, M and Sander, C and Kirkwood, JM and Lee, S (2014) A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma. Journal of Translational Medicine, 12 (1).

Vujanovic, Lazar and Stahl, Elizabeth and Butterfield, Lisa H (2014) Alpha fetoprotein directly induces a unique pro-inflammatory, IL-2 hyperresponsive phenotype in human natural killer cells. Journal for ImmunoTherapy of Cancer, 2 (S3).

Wei, J and Zhou, Y and Jiang, GQ and Xiao, D (2014) Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1. Cancer Cell International, 14 (1).